Article
Landscape of Cyclin Pathway Genomic Alterations Across 5,356 Prostate Cancers: Implications for Targeted Therapeutics.
The oncologist - 1 Apr 2021
Jardim Denis L, Millis Sherri Z, Ross Jeffrey S, Woo Michelle Sue-Ann, Ali Siraj M, Kurzrock Razelle
Abstract excerpt
The cyclin pathway may confer resistance to standard treatments but also offer novel therapeutic opportunities in prostate cancer. Herein, we analyzed prostate cancer samples (majority metastatic) using comprehensive genomic profiling performed by next-generation sequencing (315 genes, >500× coverage) for alterations in activating and sensitizing cyclin genes (CDK4 amplification, CDK6 amplification, CCND1, CCND2,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
